Clinical Trial Update: Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer [NA]

View source ↗

Summary

A clinical trial is exploring the safety and efficacy of trastuzumab deruxtecan (T-DXd) given concurrently with brain radiotherapy in patients with brain metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: QIAO LI | Conditions: Breast Cancer | NA | Status: RECRUITING